When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...

A new chimeric antigen receptor (CAR) T cell therapy called AIC100 ... have demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne ...

UCSF grad students present research about how to track down HIV, fight brain tumors with T cells and treat brain disorders prenatally. [VIDEO] ...

But sometimes even those don’t sit well and you just can’t face eating one more. So, that’s when gel alternatives come in handy. Some runners will carry candy, dates, or even grab sliced ...

The endocannabinoid system (ECS) is a complex cell-signaling ... aren’t completely sure how CBD interacts with the ECS. But they do know that it doesn’t bind to CB1 or CB2 receptors the ...

Abpro Holdings, Inc. and Celltrion have announced a strategic partnership for the global development of ABP-102/CT-P72, a bispecific T-cell engager designed to target HER2-positive cancers ...

If you or a loved one has diffuse large B-cell lymphoma (DLBCL) that is no longer responding to treatment or came back after treatment, chimeric antigen receptor (CAR) T-cell therapy may be an option.

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...

There's something else to keep in mind when looking for the best family cell phone plans: unlimited data is the way to go more often than not. That way, you don't have to worry about running out ...

engineered T-cell receptor T-cell therapy (TCR T) that targets PRAME, an intracellular protein displayed as a peptide antigen on the surface of multiple solid tumors via HLA-A*02:01, with minimal ...

CAR T-cell therapy, short for chimeric antigen receptor T-cell therapy, has already shown remarkable success in treating blood cancers like leukemia. This personalized treatment involves extracting a ...